Gynecologic cancers metastatic to the breast

David H. Moore, Derron K. Wilson, Jean A. Hurteau, Katherine Y. Look, Frederick B. Stehman, Gregory P. Sutton

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: We report a series of gynecologic cancers metastatic to the breast, illustrating the diagnostic and prognostic implications of this rare event. Study Design: By reviewing the gynecologic oncology data base, we identified 10 women with gynecologic cancer metastatic to the breast who were treated at Indiana University School of Medicine between August 1978 and February 1995. Medical records were reviewed for pertinent data concerning the presentation, evaluation, and treatment of the primary gynecologic malignancy and the metastatic breast tumor. Results: The mean patient age was 56.8 years (range, 30-80 years). The most common gynecologic malignancy was ovarian cancer (five patients), followed by cervical cancer (two patients) and cancers of the vagina, endometrium, or peritoneum (one patient each). A palpable solitary breast mass was found in 8 of 10 patients (80%), and the upper outer quadrant of the breast was the most common site of tumor involvement. One woman presented with examination findings resembling inflammatory breast cancer, and one patient presented with multiple firm subcutaneous nodules. Despite further treatment, which in all cases consisted of systemic chemotherapy, 83% of the patients died with a breast metastasis within 1 year of presentation. Conclusions: Secondary breast malignancy should be suspected in any patient with a breast tumor and a known history of gynecologic cancer. A breast metastasis implies widespread tumor dissemination and a poor prognosis. Radical breast surgery should be avoided.

Original languageEnglish (US)
Pages (from-to)178-181
Number of pages4
JournalJournal of the American College of Surgeons
Volume187
Issue number2
DOIs
StatePublished - Aug 24 1998

Fingerprint

Breast
Neoplasms
Vaginal Neoplasms
Inflammatory Breast Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Peritoneum
Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
Medical Records
Medicine
Databases
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Moore, D. H., Wilson, D. K., Hurteau, J. A., Look, K. Y., Stehman, F. B., & Sutton, G. P. (1998). Gynecologic cancers metastatic to the breast. Journal of the American College of Surgeons, 187(2), 178-181. https://doi.org/10.1016/S1072-7515(98)00119-7

Gynecologic cancers metastatic to the breast. / Moore, David H.; Wilson, Derron K.; Hurteau, Jean A.; Look, Katherine Y.; Stehman, Frederick B.; Sutton, Gregory P.

In: Journal of the American College of Surgeons, Vol. 187, No. 2, 24.08.1998, p. 178-181.

Research output: Contribution to journalArticle

Moore, DH, Wilson, DK, Hurteau, JA, Look, KY, Stehman, FB & Sutton, GP 1998, 'Gynecologic cancers metastatic to the breast', Journal of the American College of Surgeons, vol. 187, no. 2, pp. 178-181. https://doi.org/10.1016/S1072-7515(98)00119-7
Moore, David H. ; Wilson, Derron K. ; Hurteau, Jean A. ; Look, Katherine Y. ; Stehman, Frederick B. ; Sutton, Gregory P. / Gynecologic cancers metastatic to the breast. In: Journal of the American College of Surgeons. 1998 ; Vol. 187, No. 2. pp. 178-181.
@article{10a1734ad0d1403c816644cab9e75dce,
title = "Gynecologic cancers metastatic to the breast",
abstract = "Background: We report a series of gynecologic cancers metastatic to the breast, illustrating the diagnostic and prognostic implications of this rare event. Study Design: By reviewing the gynecologic oncology data base, we identified 10 women with gynecologic cancer metastatic to the breast who were treated at Indiana University School of Medicine between August 1978 and February 1995. Medical records were reviewed for pertinent data concerning the presentation, evaluation, and treatment of the primary gynecologic malignancy and the metastatic breast tumor. Results: The mean patient age was 56.8 years (range, 30-80 years). The most common gynecologic malignancy was ovarian cancer (five patients), followed by cervical cancer (two patients) and cancers of the vagina, endometrium, or peritoneum (one patient each). A palpable solitary breast mass was found in 8 of 10 patients (80{\%}), and the upper outer quadrant of the breast was the most common site of tumor involvement. One woman presented with examination findings resembling inflammatory breast cancer, and one patient presented with multiple firm subcutaneous nodules. Despite further treatment, which in all cases consisted of systemic chemotherapy, 83{\%} of the patients died with a breast metastasis within 1 year of presentation. Conclusions: Secondary breast malignancy should be suspected in any patient with a breast tumor and a known history of gynecologic cancer. A breast metastasis implies widespread tumor dissemination and a poor prognosis. Radical breast surgery should be avoided.",
author = "Moore, {David H.} and Wilson, {Derron K.} and Hurteau, {Jean A.} and Look, {Katherine Y.} and Stehman, {Frederick B.} and Sutton, {Gregory P.}",
year = "1998",
month = "8",
day = "24",
doi = "10.1016/S1072-7515(98)00119-7",
language = "English (US)",
volume = "187",
pages = "178--181",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Gynecologic cancers metastatic to the breast

AU - Moore, David H.

AU - Wilson, Derron K.

AU - Hurteau, Jean A.

AU - Look, Katherine Y.

AU - Stehman, Frederick B.

AU - Sutton, Gregory P.

PY - 1998/8/24

Y1 - 1998/8/24

N2 - Background: We report a series of gynecologic cancers metastatic to the breast, illustrating the diagnostic and prognostic implications of this rare event. Study Design: By reviewing the gynecologic oncology data base, we identified 10 women with gynecologic cancer metastatic to the breast who were treated at Indiana University School of Medicine between August 1978 and February 1995. Medical records were reviewed for pertinent data concerning the presentation, evaluation, and treatment of the primary gynecologic malignancy and the metastatic breast tumor. Results: The mean patient age was 56.8 years (range, 30-80 years). The most common gynecologic malignancy was ovarian cancer (five patients), followed by cervical cancer (two patients) and cancers of the vagina, endometrium, or peritoneum (one patient each). A palpable solitary breast mass was found in 8 of 10 patients (80%), and the upper outer quadrant of the breast was the most common site of tumor involvement. One woman presented with examination findings resembling inflammatory breast cancer, and one patient presented with multiple firm subcutaneous nodules. Despite further treatment, which in all cases consisted of systemic chemotherapy, 83% of the patients died with a breast metastasis within 1 year of presentation. Conclusions: Secondary breast malignancy should be suspected in any patient with a breast tumor and a known history of gynecologic cancer. A breast metastasis implies widespread tumor dissemination and a poor prognosis. Radical breast surgery should be avoided.

AB - Background: We report a series of gynecologic cancers metastatic to the breast, illustrating the diagnostic and prognostic implications of this rare event. Study Design: By reviewing the gynecologic oncology data base, we identified 10 women with gynecologic cancer metastatic to the breast who were treated at Indiana University School of Medicine between August 1978 and February 1995. Medical records were reviewed for pertinent data concerning the presentation, evaluation, and treatment of the primary gynecologic malignancy and the metastatic breast tumor. Results: The mean patient age was 56.8 years (range, 30-80 years). The most common gynecologic malignancy was ovarian cancer (five patients), followed by cervical cancer (two patients) and cancers of the vagina, endometrium, or peritoneum (one patient each). A palpable solitary breast mass was found in 8 of 10 patients (80%), and the upper outer quadrant of the breast was the most common site of tumor involvement. One woman presented with examination findings resembling inflammatory breast cancer, and one patient presented with multiple firm subcutaneous nodules. Despite further treatment, which in all cases consisted of systemic chemotherapy, 83% of the patients died with a breast metastasis within 1 year of presentation. Conclusions: Secondary breast malignancy should be suspected in any patient with a breast tumor and a known history of gynecologic cancer. A breast metastasis implies widespread tumor dissemination and a poor prognosis. Radical breast surgery should be avoided.

UR - http://www.scopus.com/inward/record.url?scp=0031855937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031855937&partnerID=8YFLogxK

U2 - 10.1016/S1072-7515(98)00119-7

DO - 10.1016/S1072-7515(98)00119-7

M3 - Article

C2 - 9704965

AN - SCOPUS:0031855937

VL - 187

SP - 178

EP - 181

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 2

ER -